What are the major opportunities in the Radiopharmaceutical Theranostics market? What are the strategies for the Radiopharmaceutical Theranostics market?

For detailed insights on the major opportunities and strategies in the Radiopharmaceutical Theranostics market, Read More

How does the Radiopharmaceutical Theranostics market relate to the overall economy and other similar markets?

For detailed insights on Radiopharmaceutical Theranostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Radiopharmaceutical Theranostics market growth? SWOT analysis of the Radiopharmaceutical Theranostics market.

For detailed insights on the key dynamics influencing the Radiopharmaceutical Theranostics market growth and SWOT analysis of the Radiopharmaceutical Theranostics industry, Read More

Radiopharmaceutical Theranostics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Radiopharmaceutical Theranostics Market Report 2026

Name: Radiopharmaceutical Theranostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers), By Source (Nuclear Reactors, Cyclotrons), By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes), By Indication (Oncology, Cardiology, Neurology, Other Indications), By End User (Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Radiopharmaceutical Theranostics Market Overview

• Radiopharmaceutical Theranostics market size has reached to $3.27 billion in 2025

• Expected to grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%

• Growth Driver: The Surge In Cancer Incidence Boosts Radiopharmaceutical Theranostics Market Growth

• Market Trend: Advancements In Theranostics For Targeted Cancer Treatment By Major Companies In Radiopharmaceutical Market

• North America was the largest region in 2025.

What Is Covered Under Radiopharmaceutical Theranostics Market?

Radiopharmaceutical theranostics refers to a combined approach in medicine that combines therapeutics (treatment) and diagnostics (diagnosis) using radiopharmaceuticals. These are used for patient diagnosis, therapy, and personalized management.

The main product types of radiopharmaceutical theranostics are alpha emitters, beta emitters, and positron emission tomography (pet) tracers. Alpha emitters refer to radioactive substances that emit alpha particles, which are high-energy particles consisting of two protons and two neutrons. The various sources include nuclear reactors, cyclotrons, and the various radioisotopes include technetium-99, gallium-68, iodine-131, iodine-123, 18F, Y-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. These various indications include oncology, cardiology, neurology, and other indications and are used by various end-users such as hospitals, diagnostic imaging centers, academic and research institutes, and others.

Radiopharmaceutical Theranostics Market Global Report 2026 Market Report bar graph

What Is The Radiopharmaceutical Theranostics Market Size and Share 2026?

The radiopharmaceutical theranostics market size has grown rapidly in recent years. It will grow from $3.27 billion in 2025 to $3.76 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to expansion of nuclear medicine applications, increasing cancer incidence rates, advancements in radioisotope production techniques, growth in diagnostic imaging integration, early adoption of theranostic treatment models.

What Is The Radiopharmaceutical Theranostics Market Growth Forecast?

The radiopharmaceutical theranostics market size is expected to see rapid growth in the next few years. It will grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing investments in precision oncology, rising demand for personalized radiopharmaceutical therapies, expansion of clinical trials for novel isotopes, increasing collaboration between diagnostics and therapeutics, ongoing innovation in isotope supply chains. Major trends in the forecast period include increasing development of targeted theranostic radiopharmaceuticals, rising use of pet-based personalized therapies, growing adoption of alpha and beta emitters in oncology, expansion of cyclotron-based isotope production, enhanced focus on precision oncology applications.

Book your 30 minutes free consultation with our research experts

Global Radiopharmaceutical Theranostics Market Segmentation

1) By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers

2) By Source: Nuclear Reactors, Cyclotrons

3) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes

4) By Indication: Oncology, Cardiology, Neurology, Other Indications

5) By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals

2) By Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals

3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers

What Is The Driver Of The Radiopharmaceutical Theranostics Market?

The rising incidence of cancer is expected to propel the growth of the radiopharmaceutical theranostics market going forward. Cancer refers to a disease or condition of complex and abnormal growth of cells that can invade and spread to other parts of the body. Radiopharmaceutical theranostics helps in cancer treatment by providing targeted and personalized approaches. For instance, in 2023, according to the American Cancer Society, a US-based voluntary cancer health organization, in the US, 1.9 million new cancer cases are estimated to be diagnosed and about 609,820 deaths may occur due to cancer. Further, 88% of the people diagnosed are expected to belong to the 50 years or above age group. Therefore, the rising incidence of cancer is driving the growth of the radiopharmaceutical theranostics industry.

Key Players In The Global Radiopharmaceutical Theranostics Market

Major companies operating in the radiopharmaceutical theranostics market are Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.

Global Radiopharmaceutical Theranostics Market Trends and Insights

Major companies operating in the radiopharmaceutical theranostics market are focusing on developing theranostics aimed at curing cancer. Theranostic approaches are being explored for the treatment of rare diseases, with efforts to provide targeted therapies and diagnostic solutions for patients with limited treatment options such as cancer. For instance, in November 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched theranostics solutions for cancer. Theranostics is a new field of precision medicine that uses therapeutic agents in combination with imaging technology to identify and target cancer cells for destruction.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Radiopharmaceutical Theranostics Market?

In March 2023, Radiopharm Theranostics, an Australia-based biotechnology company specializing in radiopharmaceutical products, acquired Pharma15 Corporation for $4 million. Through this acquisition, Radiopharm aims to explore the potential of next-generation radiopharmaceuticals for the treatment of prostate cancer, with a focus on surpassing PSMA-based therapies and advancing innovative solutions for patients. Pharma15 Corporation is a US-based pharmaceutical company that specializes in the development of radio-immuno-theranostics platforms and pharmaceutical products.

Regional Outlook

North America was the largest region in the radiopharmaceutical theranostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiopharmaceutical Theranostics Market?

The radiopharmaceutical theranostics market includes revenues earned by providing genetic testing, targeted therapy services, contract development, and manufacturing services, consultation and interpretation, and personalized therapeutic interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiopharmaceutical Theranostics Market Report 2026?

The radiopharmaceutical theranostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceutical theranostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Radiopharmaceutical Theranostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.76 billion
Revenue Forecast In 2035	$6.64 billion
Growth Rate	CAGR of 15.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Source, Radioisotope, Indication, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Radiopharmaceutical Theranostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Radiopharmaceutical Theranostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Radiopharmaceutical Theranostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Radiopharmaceutical Theranostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Theranostic Radiopharmaceuticals

4.2.2 Rising Use Of Pet-Based Personalized Therapies

4.2.3 Growing Adoption Of Alpha And Beta Emitters In Oncology

4.2.4 Expansion Of Cyclotron-Based Isotope Production

4.2.5 Enhanced Focus On Precision Oncology Applications

5. Radiopharmaceutical Theranostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Imaging Centers

5.3 Cancer Treatment Centers

5.4 Academic And Research Institutes

5.5 Nuclear Medicine Clinics

6. Radiopharmaceutical Theranostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Radiopharmaceutical Theranostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Radiopharmaceutical Theranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Radiopharmaceutical Theranostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Radiopharmaceutical Theranostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Radiopharmaceutical Theranostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Radiopharmaceutical Theranostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Radiopharmaceutical Theranostics Market Segmentation

9.1. Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers

9.2. Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nuclear Reactors, Cyclotrons

9.3. Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes

9.4. Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Neurology, Other Indications

9.5. Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users

9.6. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals

9.7. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals

9.8. Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers

10. Radiopharmaceutical Theranostics Market Regional And Country Analysis

10.1. Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Radiopharmaceutical Theranostics Market

11.1. Asia-Pacific Radiopharmaceutical Theranostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Radiopharmaceutical Theranostics Market

12.1. China Radiopharmaceutical Theranostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Radiopharmaceutical Theranostics Market

13.1. India Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Radiopharmaceutical Theranostics Market

14.1. Japan Radiopharmaceutical Theranostics Market Overview

14.2. Japan Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Radiopharmaceutical Theranostics Market

15.1. Australia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Radiopharmaceutical Theranostics Market

16.1. Indonesia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Radiopharmaceutical Theranostics Market

17.1. South Korea Radiopharmaceutical Theranostics Market Overview

17.2. South Korea Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Radiopharmaceutical Theranostics Market

18.1. Taiwan Radiopharmaceutical Theranostics Market Overview

18.2. Taiwan Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Radiopharmaceutical Theranostics Market

19.1. South East Asia Radiopharmaceutical Theranostics Market Overview

19.2. South East Asia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Radiopharmaceutical Theranostics Market

20.1. Western Europe Radiopharmaceutical Theranostics Market Overview

20.2. Western Europe Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Radiopharmaceutical Theranostics Market

21.1. UK Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Radiopharmaceutical Theranostics Market

22.1. Germany Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Radiopharmaceutical Theranostics Market

23.1. France Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Radiopharmaceutical Theranostics Market

24.1. Italy Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Radiopharmaceutical Theranostics Market

25.1. Spain Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Radiopharmaceutical Theranostics Market

26.1. Eastern Europe Radiopharmaceutical Theranostics Market Overview

26.2. Eastern Europe Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Radiopharmaceutical Theranostics Market

27.1. Russia Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Radiopharmaceutical Theranostics Market

28.1. North America Radiopharmaceutical Theranostics Market Overview

28.2. North America Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Radiopharmaceutical Theranostics Market

29.1. USA Radiopharmaceutical Theranostics Market Overview

29.2. USA Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Radiopharmaceutical Theranostics Market

30.1. Canada Radiopharmaceutical Theranostics Market Overview

30.2. Canada Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Radiopharmaceutical Theranostics Market

31.1. South America Radiopharmaceutical Theranostics Market Overview

31.2. South America Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Radiopharmaceutical Theranostics Market

32.1. Brazil Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Radiopharmaceutical Theranostics Market

33.1. Middle East Radiopharmaceutical Theranostics Market Overview

33.2. Middle East Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Radiopharmaceutical Theranostics Market

34.1. Africa Radiopharmaceutical Theranostics Market Overview

34.2. Africa Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Radiopharmaceutical Theranostics Market Regulatory and Investment Landscape

36. Radiopharmaceutical Theranostics Market Competitive Landscape And Company Profiles

36.1. Radiopharmaceutical Theranostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Radiopharmaceutical Theranostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Radiopharmaceutical Theranostics Market Company Profiles

36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. China Grand Pharmaceutical & Healthcare. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lantheus Medical Imaging Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Radiopharmaceutical Theranostics Market Other Major And Innovative Companies

Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc

38. Global Radiopharmaceutical Theranostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Radiopharmaceutical Theranostics Market

40. Radiopharmaceutical Theranostics Market High Potential Countries, Segments and Strategies

40.1 Radiopharmaceutical Theranostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Radiopharmaceutical Theranostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Radiopharmaceutical Theranostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Radiopharmaceutical Theranostics Market, Overview Of Key Products - Product Examples

Table 2: Global Radiopharmaceutical Theranostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Radiopharmaceutical Theranostics Market, Supply Chain Analysis

Table 4: Global Radiopharmaceutical Theranostics Market, Major Raw Material Providers

Table 5: Global Radiopharmaceutical Theranostics Market, Major Resource Providers

Table 6: Global Radiopharmaceutical Theranostics Market, Major Manufacturers (Suppliers)

Table 7: Global Radiopharmaceutical Theranostics Market, Major Distributors And Channel Partners

Table 8: Global Radiopharmaceutical Theranostics Market, Key Technologies & Future Trends

Table 9: Global Radiopharmaceutical Theranostics Market, Major Trends

Table 10: Global Radiopharmaceutical Theranostics Market, Major End Users

Table 11: Global Radiopharmaceutical Theranostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Radiopharmaceutical Theranostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Radiopharmaceutical Theranostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Radiopharmaceutical Theranostics Market - TAM, US$ Billion, 2025

Table 15: Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Radiopharmaceutical Theranostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Radiopharmaceutical Theranostics Market - Company Scoring Matrix

Table 99: Cardinal Health Inc. Financial Performance

Table 100: GE HealthCare Technologies Inc. Financial Performance

Table 101: Bayer AG Financial Performance

Table 102: China Grand Pharmaceutical & Healthcare. Financial Performance

Table 103: Lantheus Medical Imaging Inc. Financial Performance

Table 104: Global Radiopharmaceutical Theranostics Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Radiopharmaceutical Theranostics Market, Competitive Dashboard

Table 106: Global Radiopharmaceutical Theranostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 108: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Source, 2025 – 2030

Table 109: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Radioisotope, 2025 – 2030

List Of Figures

Figure 1: Global Radiopharmaceutical Theranostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Radiopharmaceutical Theranostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Radiopharmaceutical Theranostics Market, Supply Chain Analysis

Figure 4: Global Radiopharmaceutical Theranostics Market, Major Raw Material Providers

Figure 5: Global Radiopharmaceutical Theranostics Market, Major Resource Providers

Figure 6: Global Radiopharmaceutical Theranostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Radiopharmaceutical Theranostics Market, Major Distributors And Channel Partners

Figure 8: Global Radiopharmaceutical Theranostics Market, Key Technologies & Future Trends

Figure 9: Global Radiopharmaceutical Theranostics Market, Major Trends

Figure 10: Global Radiopharmaceutical Theranostics Market, Major End Users

Figure 11: Global Radiopharmaceutical Theranostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Radiopharmaceutical Theranostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Radiopharmaceutical Theranostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Radiopharmaceutical Theranostics Market - TAM, US$ Billion, 2025

Figure 15: Global Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Radiopharmaceutical Theranostics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Radiopharmaceutical Theranostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Alpha Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Beta Emitters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Radiopharmaceutical Theranostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Tracers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Radiopharmaceutical Theranostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Radiopharmaceutical Theranostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Radiopharmaceutical Theranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Radiopharmaceutical Theranostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Radiopharmaceutical Theranostics Market - Company Scoring Matrix

Figure 99: Cardinal Health Inc. Financial Performance

Figure 100: GE HealthCare Technologies Inc. Financial Performance

Figure 101: Bayer AG Financial Performance

Figure 102: China Grand Pharmaceutical & Healthcare. Financial Performance

Figure 103: Lantheus Medical Imaging Inc. Financial Performance

Figure 104: Global Radiopharmaceutical Theranostics Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Radiopharmaceutical Theranostics Market, Competitive Dashboard

Figure 106: Global Radiopharmaceutical Theranostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 108: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Source, 2025 – 2030

Figure 109: Global, Radiopharmaceutical Theranostics Market Size Gain ($ Billion), Segmentation By Radioisotope, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Theranostics Market Report 2026 - Global Outlook – By Disease Type (Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases), By Technology (Polymerase Chain Reaction, ...

Nuclear Medicine Radioisotopes Market Report 2026 - Global Outlook – By Type (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), R...

Radiotheranostics Market Report 2026 - Global Outlook – By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioi...

Diagnostic Radioisotopes Market Report 2026 - Global Outlook – By Radioisotope (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes), By Imaging Modality (Sing...

Radiotherapy Devices Market Report 2026 - Global Outlook – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prosta...

Medical Irradiation Market Report 2026 - Global Outlook – By Disease Type (Trisomy 21, Translocation Medical Irradiation, Mosaic Medical Irradiation), By Treatment (Diagnosis, Therapy), By Distribution Channel (Direct Te...

Osimertinib Drugs Market Report 2026 - Global Outlook – By Type (40 mg, 80 mg), By Distribution Channel (Hospital Pharmacy, Drug Store And Retail Pharmacy, Online Pharmacy), By Application (Locally Advanced Non-Small Cel...

Frequently Asked Questions

How big is the Radiopharmaceutical Theranostics Market?

The Radiopharmaceutical Theranostics market was valued at $3.27 billion in 2025, increased to $3.76 billion in 2026, and is projected to reach $6.64 billion by 2030.

What is the Radiopharmaceutical Theranostics market growth?

The global Radiopharmaceutical Theranostics market is expected to grow at a CAGR of 15.3% from 2026 to 2035 to reach $6.64 billion by 2035.

Who are the key players in Radiopharmaceutical Theranostics market?

Some Key Players in the Radiopharmaceutical Theranostics market Include, Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd. .

What is the anticipated growth trend for the Radiopharmaceutical Theranostics market?

Major trend in this market includes: Advancements In Theranostics For Targeted Cancer Treatment By Major Companies In Radiopharmaceutical Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Radiopharmaceutical Theranostics market?

North America was the largest region in the radiopharmaceutical theranostics market in 2025. The regions covered in the radiopharmaceutical theranostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.